Altitude is a phenotypic modifier in hereditary paraganglioma type�1: evidence for an oxygen-sensing defect
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Hereditary paraganglioma type 1 (PGL1) is characterized by slow-growing and vascularized tumors that often develop in the carotid body (CB) and is caused by mutations in the gene for succinate dehydrogenase D ( SDHD) of mitochondrial complex II. The mechanisms of tumorigenesis and the factors affecting penetrance and expressivity are unknown. Because chronic hypoxic stimulation at high altitudes causes sporadic CB paragangliomas, it has been hypothesized that the SDHD gene product may be involved in oxygen sensing. On this background, we examined genotype-phenotype-environment relationships and tested whether higher altitudes adversely affect the phenotype in PGL1. An analysis of 58 subjects from 23 families revealed that nonsense/splicing mutation carriers developed symptoms 8.5 years earlier than missense mutation carriers ( P<0.012). We also found that subjects who were diagnosed with single tumors at their first clinical evaluation lived at lower average altitudes and were exposed to lower altitude-years than those with multiple tumors ( P<0.012). Pheochromocytomas developed in six subjects (approximately 10%), five of whom had nonsense mutations ( P=0.052). Subjects with pheochromocytomas also lived at higher average altitudes and were exposed to higher altitude-years than those without them ( P=0.026). To test whether altitude is also associated with the more frequent detection of germ-line founder mutations among sporadic cases in The Netherlands than in the USA ( P=0.00033), we calculated population-weighted elevations of the two countries. We found that the population-weighted elevations were approximately 260 m for the US and 2 m for the central-western Netherlands ( P~0), where three Dutch founder mutations were discovered. This finding suggests that low altitudes in The Netherlands reduce penetrance and relax the natural selection on SDHD mutations. Collectively, these data suggest that higher altitudes and nonsense/splicing mutations are associated with phenotypic severity in PGL1 and support the hypothesis that SDHD mutations impair oxygen sensing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, the numbers of carotid body paragangliomas are increased in populations living at higher altitudes (2), which suggests that the pathways activated by Sdh mutations overlap with those activated by hypoxia.”
Citations
Cites
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · cited 1×
“Notably, the VHL gene mutated in Von-Hippel Lindau syndrome, another cause of heritable PHEOs, is also proposed to function in oxygen homeostasis in the normoxic degradation of hypoxia-inducible factor 1 alpha (Maxwell et al. 1999).”
BackgroundMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 9×
“The genomic imprinting rule in disease transmission has not been violated in any PGL1-linked pedigree (Heutink et al. 1992; Baysal et al. 1997, 1999), although the molecular basis of imprinting is as yet unknown: SDHD shows biallelic expression in several tested tissues (Baysal et al. 2000).”
BackgroundMethodInfluentialSelf-citationGerm-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087 · cited 6×
“These mutations include IVS1+2T→G, A13 fs, W5X, C11X, R22X, S32 fs, R38X, and Q121X (Gimm et al. 2000; Astuti et al. 2001a; Neumann et al. 2002).”
BackgroundInfluentialCarotid body chemoreceptors: from natural stimuli to sensory discharges.
Gonzalez, C., Almaraz, L., Obeso, A., & Rigual, R. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.4.829 · Cited by 993
Architecture of succinate dehydrogenase and reactive oxygen species generation
Yankovskaya, V., Horsefield, R., Törnroth, S., Luna-Chavez, C., Miyoshi, H., Léger, C., Byrne, B., Cecchini, G., & Iwata, S. (2003) · Science · doi:10.1126/science.1079605 · Cited by 927 · cited 1×
“However, its precise function in MTCII remains unclear (Hederstedt 2003; Yankovskaya et al. 2003).”
BackgroundMutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875 · cited 2×
“Mutations in SDHC (PGL3) and SDHB (PGL4) have subsequently been discovered in other paraganglioma families by direct candidate gene analyses (Niemann and Muller 2000; Astuti et al. 2001b).”
BackgroundA mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes.
Ishii, N., Fujii, M., Hartman, P. S., Tsuda, M., Yasuda, K., Senoo-Matsuda, N., Yanase, S., Ayusawa, D., & Suzuki, K. (1998) · Nature · doi:10.1038/29331 · Cited by 687 · cited 4×
“Enzymatic studies in Caenorhabditis elegans (Ishii et al. 1998) and hu-”
BackgroundInfluentialCellular oxygen sensing by mitochondria: old questions, new insight
Chandel, N. S., & Schumacker, P. T. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.5.1880 · Cited by 391
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Mourad, J.-J., Plouin, P.-F., Corvol, P., Rötig, A., & Jeunemaitre, X. (2001) · The American Journal of Human Genetics · doi:10.1086/324413 · Cited by 364 · cited 4×
“Together, these three studies describe 83 “unrelated” PGL1 families and subjects attributable to three founder mutations in the central and western parts of The Netherlands, in stark contrast to the 25 distinct SDHD mutations (reviewed in Baysal 2002) reported thus far among 43 independent familial and nonfamilial cas…”
BackgroundInfluential
Cited by
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Sabharwal, S. S., & Schumacker, P. T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3803 · Cited by 1,622
Cooper, D. N., Krawczak, M., Polychronakos, C., Tyler-Smith, C., & Kehrer-Sawatzki, H. (2013) · Human Genetics · doi:10.1007/s00439-013-1331-2 · Cited by 645
Mitochondrial tumour suppressors: a genetic and biochemical update
Gottlieb, E., & Tomlinson, I. P. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1737 · Cited by 621
Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes
Benn, D. E., Gimenez-Roqueplo, A.-P., Reilly, J. R., Bertherat, J., Burgess, J., Byth, K., Croxson, M., Dahia, P. L. M., Elston, M., Gimm, O., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1862 · Cited by 570
Determining Global Population Distribution: Methods, Applications and Data
Balk, D. L., Deichmann, U., Yetman, G., Pozzi, F., Hay, S. I., & Nelson, A. (2006) · Advances in Parasitology · doi:10.1016/s0065-308x(05)62004-0 · Cited by 490
Metadata
- Authors
- Astrom, K., Cohen, J. E., Willett-Brozick, J. E., Aston, C. E., & Baysal, B. E.
- Affiliations
- University of Pittsburgh (US)
- Rockefeller University (US)
- Oklahoma Medical Research Foundation (US)
- Corresponding author
- Baysal, Bora E.
- Venue
- Human Genetics
- Published
- 2003-08-01
- Volume
- 113
- Issue
- 3
- Pages
- 228-237
- ISSN
- 0018-7348 (ISSN-L)
- 0340-6717
- 1432-1203
- OpenAlex
- W2153948449
- Cited by
- 187
- References
- 35
- Citations by year
- 2025: 3 · 2024: 5 · 2023: 8 · 2022: 7 · 2021: 15 · 2020: 4 · 2019: 10 · 2018: 10 · 2017: 4 · 2016: 3 · 2015: 11 · 2014: 7 · 2013: 7 · 2012: 4
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Human Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation
- University of Pittsburgh
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Physiology (medical) › High Altitude and Hypoxia
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- SDHD mutation, succinate dehydrogenase, altitude, hypoxia, oxygen sensing, carotid body paraganglioma, pheochromocytoma, nonsense mutation, splicing mutation, founder mutation, penetrance, carcinogenesis
- MeSH terms
- Adrenal Gland Neoplasms, Altitude, Carotid Body Tumor, Genetics, Population, Humans, Netherlands, Oxygen, Paraganglioma, Extra-Adrenal, Phenotype, Pheochromocytoma, Succinate Dehydrogenase, United States, Genetic Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Altitude is a phenotypic modifier in hereditary paraganglioma type�1: evidence for an oxygen-sensing defect. https://app.cochat.ai/papers/10.1007/s00439-003-0969-6
- The paper
- Astrom, K., Cohen, J. E., Willett-Brozick, J. E., Aston, C. E., & Baysal, B. E. (2003). Altitude is a phenotypic modifier in hereditary paraganglioma type�1: evidence for an oxygen-sensing defect. Human Genetics. https://doi.org/10.1007/s00439-003-0969-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.